Global Oncology/Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Sep-2018
No. of pages: 122

Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents.

Scope of the Report:

This report focuses on the Oncology/Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

USFDA and European Union have undertaken significant initiatives to fuel the growth of global oncology/cancer drugs market by providing pre-market approval for potential drugs under clinical development.

Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe

Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population.

The worldwide market for Oncology/Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Amgen

- Johnson & Johnson

- GlaxoSmithKline

- Eli lilly

- Roche diagnostics

- Novartis

- Pfizer

- Merck

- Sanofi

- Celgene

- Roche

- Novartis

- Celgene

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Skin Cancer

- Other Cancers

Market Segment by Applications, can be divided into

- Hospital

- Clinic

- Pharmacy

There are 15 Chapters to deeply display the global Oncology/Cancer Drugs market.

Chapter 1, to describe Oncology/Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oncology/Cancer Drugs, with sales, revenue, and price of Oncology/Cancer Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology/Cancer Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oncology/Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Oncology/Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Oncology/Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Blood Cancer
1.2.2 Breast Cancer
1.2.3 Gastrointestinal Cancer
1.2.4 Prostate Cancer
1.2.5 Respiratory/Lung Cancer
1.2.6 Skin Cancer
1.2.7 Other Cancers
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Oncology/Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Oncology/Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Oncology/Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli lilly
2.4.1 Business Overview
2.4.2 Oncology/Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche diagnostics
2.5.1 Business Overview
2.5.2 Oncology/Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Oncology/Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Oncology/Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Oncology/Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Oncology/Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Celgene
2.10.1 Business Overview
2.10.2 Oncology/Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roche
2.11.1 Business Overview
2.11.2 Oncology/Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novartis
2.12.1 Business Overview
2.12.2 Oncology/Cancer Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Celgene
2.13.1 Business Overview
2.13.2 Oncology/Cancer Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncology/Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oncology/Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oncology/Cancer Drugs Market Analysis by Regions
4.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.5 South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5 North America Oncology/Cancer Drugs by Countries
5.1 North America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6 Europe Oncology/Cancer Drugs by Countries
6.1 Europe Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.3 UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.4 France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oncology/Cancer Drugs by Countries
7.1 Asia-Pacific Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.5 India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8 South America Oncology/Cancer Drugs by Countries
8.1 South America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oncology/Cancer Drugs by Countries
9.1 Middle East and Africa Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
10 Global Oncology/Cancer Drugs Market Segment by Type
10.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Blood Cancer Sales Growth and Price
10.2.1 Global Blood Cancer Sales Growth (2013-2018)
10.2.2 Global Blood Cancer Price (2013-2018)
10.3 Breast Cancer Sales Growth and Price
10.3.1 Global Breast Cancer Sales Growth (2013-2018)
10.3.2 Global Breast Cancer Price (2013-2018)
10.4 Gastrointestinal Cancer Sales Growth and Price
10.4.1 Global Gastrointestinal Cancer Sales Growth (2013-2018)
10.4.2 Global Gastrointestinal Cancer Price (2013-2018)
10.5 Prostate Cancer Sales Growth and Price
10.5.1 Global Prostate Cancer Sales Growth (2013-2018)
10.5.2 Global Prostate Cancer Price (2013-2018)
10.6 Respiratory/Lung Cancer Sales Growth and Price
10.6.1 Global Respiratory/Lung Cancer Sales Growth (2013-2018)
10.6.2 Global Respiratory/Lung Cancer Price (2013-2018)
10.7 Skin Cancer Sales Growth and Price
10.7.1 Global Skin Cancer Sales Growth (2013-2018)
10.7.2 Global Skin Cancer Price (2013-2018)
10.8 Other Cancers Sales Growth and Price
10.8.1 Global Other Cancers Sales Growth (2013-2018)
10.8.2 Global Other Cancers Price (2013-2018)
11 Global Oncology/Cancer Drugs Market Segment by Application
11.1 Global Oncology/Cancer Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Pharmacy Sales Growth (2013-2018)
12 Oncology/Cancer Drugs Market Forecast (2018-2023)
12.1 Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Oncology/Cancer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.2 Europe Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.4 South America Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oncology/Cancer Drugs Market Forecast (2018-2023)
12.3 Oncology/Cancer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)
12.4 Oncology/Cancer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oncology/Cancer Drugs Picture
Table Product Specifications of Oncology/Cancer Drugs
Figure Global Sales Market Share of Oncology/Cancer Drugs by Types in 2017
Table Oncology/Cancer Drugs Types for Major Manufacturers
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Skin Cancer Picture
Figure Other Cancers Picture
Figure Oncology/Cancer Drugs Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Pharmacy Picture
Figure United States Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Oncology/Cancer Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncology/Cancer Drugs Type and Applications
Table Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Oncology/Cancer Drugs Type and Applications
Table Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Oncology/Cancer Drugs Type and Applications
Table GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli lilly Basic Information, Manufacturing Base and Competitors
Table Eli lilly Oncology/Cancer Drugs Type and Applications
Table Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche diagnostics Basic Information, Manufacturing Base and Competitors
Table Roche diagnostics Oncology/Cancer Drugs Type and Applications
Table Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oncology/Cancer Drugs Type and Applications
Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oncology/Cancer Drugs Type and Applications
Table Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oncology/Cancer Drugs Type and Applications
Table Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oncology/Cancer Drugs Type and Applications
Table Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Oncology/Cancer Drugs Type and Applications
Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Oncology/Cancer Drugs Type and Applications
Table Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oncology/Cancer Drugs Type and Applications
Table Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Oncology/Cancer Drugs Type and Applications
Table Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncology/Cancer Drugs Sales by Manufacturer (2016-2017)
Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2016
Figure Global Oncology/Cancer Drugs Sales Market Share by Manufacturer in 2017
Table Global Oncology/Cancer Drugs Revenue by Manufacturer (2016-2017)
Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Oncology/Cancer Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Oncology/Cancer Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Global Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Global Oncology/Cancer Drugs Sales by Regions (2013-2018)
Table Global Oncology/Cancer Drugs Sales Market Share by Regions (2013-2018)
Table Global Oncology/Cancer Drugs Revenue by Regions (2013-2018)
Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2013
Figure Global Oncology/Cancer Drugs Revenue Market Share by Regions in 2017
Figure North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure North America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table North America Oncology/Cancer Drugs Sales by Countries (2013-2018)
Table North America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)
Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2013
Figure North America Oncology/Cancer Drugs Sales Market Share by Countries in 2017
Table North America Oncology/Cancer Drugs Revenue by Countries (2013-2018)
Table North America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2013
Figure North America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017
Figure United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Europe Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Europe Oncology/Cancer Drugs Sales by Countries (2013-2018)
Table Europe Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)
Table Europe Oncology/Cancer Drugs Revenue by Countries (2013-2018)
Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2016
Figure Europe Oncology/Cancer Drugs Revenue Market Share by Countries in 2017
Figure Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncology/Cancer Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncology/Cancer Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Oncology/Cancer Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Oncology/Cancer Drugs Revenue Market Share by Countries 2017
Figure China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure South America Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table South America Oncology/Cancer Drugs Sales by Countries (2013-2018)
Table South America Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)
Figure South America Oncology/Cancer Drugs Sales Market Share by Countries in 2017
Table South America Oncology/Cancer Drugs Revenue by Countries (2013-2018)
Table South America Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Oncology/Cancer Drugs Revenue Market Share by Countries in 2017
Figure Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Oncology/Cancer Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncology/Cancer Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Oncology/Cancer Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
Table Global Oncology/Cancer Drugs Sales by Type (2013-2018)
Table Global Oncology/Cancer Drugs Sales Share by Type (2013-2018)
Table Global Oncology/Cancer Drugs Revenue by Type (2013-2018)
Table Global Oncology/Cancer Drugs Revenue Share by Type (2013-2018)
Figure Global Blood Cancer Sales Growth (2013-2018)
Figure Global Blood Cancer Price (2013-2018)
Figure Global Breast Cancer Sales Growth (2013-2018)
Figure Global Breast Cancer Price (2013-2018)
Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)
Figure Global Gastrointestinal Cancer Price (2013-2018)
Figure Global Prostate Cancer Sales Growth (2013-2018)
Figure Global Prostate Cancer Price (2013-2018)
Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)
Figure Global Respiratory/Lung Cancer Price (2013-2018)
Figure Global Skin Cancer Sales Growth (2013-2018)
Figure Global Skin Cancer Price (2013-2018)
Figure Global Other Cancers Sales Growth (2013-2018)
Figure Global Other Cancers Price (2013-2018)
Table Global Oncology/Cancer Drugs Sales by Application (2013-2018)
Table Global Oncology/Cancer Drugs Sales Share by Application (2013-2018)
Figure Global Clinic Sales Growth (2013-2018)
Figure Global Pharmacy Sales Growth (2013-2018)
Figure Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Oncology/Cancer Drugs Sales Forecast by Regions (2018-2023)
Table Global Oncology/Cancer Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)
Figure Europe Sales Oncology/Cancer Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Oncology/Cancer Drugs Market Forecast (2018-2023)
Figure South America Sales Oncology/Cancer Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Oncology/Cancer Drugs Market Forecast (2018-2023)
Table Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)
Table Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)
Table Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)
Table Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Actinic Keratosis Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 23-Oct-2018        Price: US 3480 Onwards        Pages: 130
    Actinic keratosis or AK is a rough, scaly patch of skin that develops due to years of sun exposure. A small percentage of actinic keratosis spots can actually turn into skin cancer, Common places for actinic keratosis to develop include face, lips, ears, scalp, neck, backs of hands, and forearms. Scope of the Report: This report focuses on the Actinic Keratosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East a......
  • Global Antibody-drug Conjugate Market Growth 2018-2023
    Published: 22-Oct-2018        Price: US 3660 Onwards        Pages: 136
    Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells. Over the next five years, LPI(LP Information) projects that Antibody-drug Conjugate will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. In this report, ......
  • Global Lentinan Market Research Report 2018
    Published: 22-Oct-2018        Price: US 2900 Onwards        Pages: 118
    This report studies the global Lentinan market status and forecast, categorizes the global Lentinan market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Panjin Gerun Biotech - Golden Horizon Biologics - Acetar Bio-Tech - Johncan Mushroom B......
  • Global DNA Repair Drugs Market Growth 2018-2023
    Published: 22-Oct-2018        Price: US 3660 Onwards        Pages: 158
    DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatme......
  • Global Topotecan Hydrochloride Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 113
    This report studies the global market size of Topotecan Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Topotecan Hydrochloride in these regions. This research report categorizes the global Topotecan Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global DNA Repair Drugs Market Insights, Forecast to 2025
    Published: 16-Oct-2018        Price: US 3900 Onwards        Pages: 123
    DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatme......
  • Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 51
    Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2018, provides an overview of the Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline landscape. Thrombotic Thrombocytopenic Purpura (TTP) is a rare blood disorder characterized by clotting in small ......
  • Sickle Cell Disease - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 219
    Sickle Cell Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease - Pipeline Review, H2 2018, provides an overview of the Sickle Cell Disease (Hematological Disorders) pipeline landscape. Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia......
  • 2018-2023 Global Doxorubicin Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Doxorubicin market for 2018-2023. Doxorubicin is a kind of antitumor antibiotics, can inhibit the synthesis of RNA and DNA, RNA in the strongest inhibitory effect. Doxorubicin has an effect on a wide variety of tumor, belongs to the cycle non-specific drug, have all sorts of growth cycle of tumor cells to kill.it's given by injection into a vein.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs